BioPharma Dive Jan 12, 2026 Best practices for COA selection: Building a stronger foundation for clinical trials
10x Genomics Blog Jan 12, 2026 Balanced Risk/Reward Keeps 10x Genomics at Hold Despite Solid Execution and Discounted Valuation - TipRanks
10x Genomics Blog Jan 12, 2026 10x Genomics (TXG) Sees Modest Q4 Growth Amid Revenue Challenges - GuruFocus
FierceBiotech Jan 12, 2026 Ohio Bets on Workforce Training to Capture Boom in Biomanufacturing, Digital Health
FierceBiotech Jan 12, 2026 Quest Diagnostics highlights role of in vitro diagnostics in precision medicine
NVIDIA Jan 12, 2026 Nvidia Partners With Biotech Firms On AI Drug Discovery - Investor's Business Daily
Catalent Jan 12, 2026 SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs - Business Wire
NVIDIA Jan 12, 2026 Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab - Yahoo Finance
NVIDIA Jan 12, 2026 NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery - NVIDIA Newsroom
10x Genomics Blog Jan 12, 2026 10x Genomics sees uptick in Q4 revenue despite softer FY sales (TXG:NASDAQ) - Seeking Alpha
10x Genomics Blog Jan 12, 2026 10X Genomics Q4 prelim revenue beats on consumables unit strength - TradingView — Track All Markets
Lonza News Jan 12, 2026 Lonza Group AG (VTX:LONN) surges 3.4%; individual investors who own 52% shares profited along with institutions - simplywall.st
Lonza News Jan 12, 2026 Lonza Group AG (VTX:LONN) surges 3.4%; individual investors who own 52% shares profited along with institutions - simplywall.st
eLife Jan 12, 2026 Linking complex microbial interactions and dysbiosis through a disordered Lotka–Volterra model